Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preeclampsia: a renal perspective.

S Ananth Karumanchi1, Sharon E Maynard, Isaac E Stillman

  • 1Renal Division and Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. sananth@bidmc.harvard.edu

Kidney International
|May 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal and fetal HLA heterozygosity in preeclampsia: Insights from a large multi-ancestry pregnancy cohort.

medRxiv : the preprint server for health sciences·2026
Same author

The role of supraoptic hypothalamic arginine vasopressin neurons in aging-associated water balance and thermoregulatory deficits in male mice.

Nature communications·2026
Same author

Placental nicotinamide adenine dinucleotide modulates the timing of labor.

Science (New York, N.Y.)·2026
Same author

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant.

Kidney international reports·2026
Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026
Same author

Associations of serum uric acid levels with podocyte injury and kidney histopathologic lesions.

Journal of nephrology·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Preeclampsia affects 5% of pregnancies, causing significant maternal and infant complications. Recent research highlights anti-angiogenic proteins from the placenta as key contributors to preeclampsia

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Pathophysiology

Background:

  • Preeclampsia is a major cause of maternal and perinatal morbidity and mortality, affecting approximately 5% of all pregnancies.
  • The exact mechanisms underlying preeclampsia pathogenesis remain incompletely understood.

Purpose of the Study:

  • To review and synthesize current knowledge on the pathogenesis of preeclampsia.
  • To emphasize the role of placental anti-angiogenic proteins in the development of preeclampsia's key features.

Main Methods:

  • Literature review of recent research on preeclampsia pathogenesis.
  • Focus on studies investigating placental factors and their systemic effects.

Main Results:

Related Experiment Videos

  • Emerging evidence points to circulating anti-angiogenic proteins originating from the placenta.
  • These proteins are implicated in the development of proteinuria and hypertension, hallmarks of preeclampsia.

    • Conclusions:

    • Anti-angiogenic proteins from the placenta are likely critical mediators in preeclampsia development.
    • Further research into these factors may offer new diagnostic and therapeutic targets for preeclampsia.